Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration

Miyachi, N; Zagrijtschuk, O; Kang, L; Yonezu, K; Qin, A

Miyachi, N (corresponding author), PharmaEssentia Japan KK, Minato Ku, Akasaka Ctr Bldg 12F,1-3-13 Moto Akasaka, Tokyo 1070051, Japan.

CLINICAL DRUG INVESTIGATION, 2021; 41 (4): 391

Abstract

Background and Objectives Ropeginterferon alfa-2b is a novel monopegylated recombinant interferon alfa-2b for the treatment of patients with polycythe......

Full Text Link